What are the symptoms of a low penetrance CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) mutation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Low penetrance CFTR mutations can cause a range of milder symptoms, including recurrent sinusitis, nasal polyps, chronic cough, bronchiectasis, and recurrent respiratory infections, as well as mild digestive issues and male infertility due to congenital bilateral absence of the vas deferens (CBAVD). These symptoms are often less severe than those experienced by individuals with classic cystic fibrosis, and may not be diagnosed until adulthood 1. Some common symptoms of low penetrance CFTR mutations include:

  • Recurrent sinusitis
  • Nasal polyps
  • Chronic cough
  • Bronchiectasis
  • Recurrent respiratory infections
  • Mild digestive issues, such as occasional abdominal pain or constipation
  • Male infertility due to CBAVD Patients with low penetrance mutations may have borderline or mildly elevated sweat chloride levels (40-60 mmol/L), rather than the higher levels seen in classic CF 1. The milder presentation of low penetrance CFTR mutations occurs because these mutations allow for some residual CFTR protein function, unlike severe mutations that completely eliminate protein function. It is essential to consider CFTR-related disorders in adults with recurrent respiratory issues or unexplained bronchiectasis, as they may not be diagnosed until adulthood 1.

From the Research

Symptoms of Low Penetrance CFTR Mutation

The symptoms of low penetrance CFTR mutation can vary, but some common manifestations include:

  • Mild or single-organ system manifestations of CFTR-related disease 2
  • Monosymptomatic or adult-onset diseases, called CFTR-related disorders 3
  • Alternative disorders, such as disseminated bronchiectasis and pancreatitis, which are also thought to result from CFTR mutations 4
  • Acquired CFTR dysfunction, which can contribute to other diseases that share clinical features of cystic fibrosis, such as asthma, allergic bronchopulmonary aspergillosis, and bronchiectasis 5

CFTR Mutation Classification

CFTR mutations can be classified into different classes based on their clinical consequences and effect on the structure and function of the CFTR channel 6. This classification is essential in the establishment of mutation-targeted therapeutic strategies. The classification of CFTR mutations includes:

  • Severe variants associated with a typical multi-organ form of cystic fibrosis
  • Mild variants involved in monosymptomatic or adult-onset diseases, called CFTR-related disorders 3
  • Complex disease alleles and modifier genes that can influence the disease phenotype 4

Genotype-Phenotype Correlation

The correlation between CFTR genotype and disease phenotype is still not well understood 4. While a connection between CFTR genotype and disease manifested in the pancreas has been well described, pulmonary disease appears to be highly variable even between individuals with the same genotype. Further research is needed to understand the relationship between CFTR genotype and disease phenotype.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

CFTR gene variants, epidemiology and molecular pathology.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2020

Research

The phenotypic consequences of CFTR mutations.

Annals of human genetics, 2003

Research

CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways.

European respiratory review : an official journal of the European Respiratory Society, 2020

Research

Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies.

The international journal of biochemistry & cell biology, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.